Search Login Register

Telangiectasis (Telangiectasia) Summary

Description: Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders.

Also Known As: Telangiectasia; Telangiectases; Spider Vein; Telangiectasias; Vein, Spider Show All >>

Networked: 1315 relevant articles (136 outcomes, 95 trials/studies) for this Disease

Key Drugs and Agents for Telangiectasis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Neodymium : 8 outcomes 3 studies in 14 results : IBA
  2. bevacizumab : 6 outcomes 1 study in 44 results : FDA 2
  3. Retinaldehyde (Retinal) : 4 outcomes 5 studies in 166 results : IBA
  4. Argon : 4 outcomes 3 studies in 26 results : IBA
  5. yttrium-aluminum-garnet : 4 outcomes 1 study in 6 results : IBA
  6. polidocanol (Laureth) : 3 outcomes 4 studies in 16 results : FDA 1
  7. Copper : 3 outcomes 3 studies in 10 results : IBA
  8. ranibizumab (Lucentis) : 3 outcomes 2 studies in 11 results : FDA 2
  9. glucuronyl glucosamine glycan sulfate (Vessel) : 3 outcomes 1 study in 33 results : IBA
  10. 1-phenyl-3,3-dimethyltriazene (PDT) : 3 outcomes in 9 results : IBA
Show All >>

Diseases Related to Telangiectasis

  1. Erythema
  2. Rosacea (Acne Rosacea)
  3. Epistaxis (Nosebleed)
  4. Telangiectasis (Telangiectasia)
  5. Hemangioma (Angioma)
Show All >>

Key Therapies for Telangiectasis

Efficacy Chart >>
  1. Lasers (Laser) : 35 outcomes 24 studies in 179 results
  2. Solid-State Lasers : 20 outcomes 10 studies in 50 results
  3. Dye Lasers : 19 outcomes 8 studies in 90 results
  4. Sclerotherapy : 16 outcomes 17 studies in 92 results
  5. Semiconductor Lasers : 6 outcomes 2 studies in 9 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.